Cancer Family
Glandular Cell Neoplasm
CI-CAN-00000188Explore in graph →
Non-malignant2,825 active trials43 approved drugs426 evidence items
- NCIt
- C7132
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000188Explore in graph →
Clinical trials
10,213 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04021069 | Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer | unknown | — | 800 | Sunnybrook Health Sciences CentreOTHER | 1 | Jul 16, 2019 | clinicaltrials |
| NCT04014101 | SHR-1210 Plus Apatinib in Patients With Advanced-Stage Hepatocellular Carcinoma(SHR-1210) | unknown | Phase 2 | 40 | Shanghai Zhongshan HospitalOTHER | 1 | Jul 11, 2019 |
| clinicaltrials |
| NCT04012021 | EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRI(EXLIPSE) | unknown | N/A | 30 | University of PisaOTHER | 1 | Jul 9, 2019 | clinicaltrials |
| NCT04011085 | Tw HER2 Positive Breast Cancer Productivity & Utility Study | unknown | — | 300 | Taiwan Epidemiology AssociationOTHER | 1 | Jul 8, 2019 | clinicaltrials |
| NCT04005118 | Human Intestinal Microbiome and Surgical Outcomes in Patients Undergoing Colorectal Cancer Surgery(Microbiota) | unknown | — | 50 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 2, 2019 | clinicaltrials |
| NCT03255135 | Initial Experience in Brazilian Single Center With High Intensity Focalized Ultrasound (HIFU) Prostate Cancer Therapy: Morbidity, Oncological and Functional Outcomes. | unknown | N/A | 130 | Hospital de Transplante Doutor Euryclides de Jesus ZerbiniOTHER | 1 | Jun 27, 2019 | clinicaltrials |
| NCT01570166 | Percutaneous Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma | unknown | N/A | 210 | Sun Yat-sen UniversityOTHER | 1 | Jun 26, 2019 | clinicaltrials |
| NCT03996681 | TACE Combined With Methylcantharidimide Tablets in the Treatment of Large and Unresectable Hepatocellular Carcinoma | unknown | Phase 4 | 22 | Suzhou Municipal HospitalOTHER | 1 | Jun 25, 2019 | clinicaltrials |
| NCT03996993 | Defining Recurrent Disease With Axumin™ | unknown | — | 20 | Cancer Center of IrvineOTHER | 1 | Jun 25, 2019 | clinicaltrials |
| NCT03990103 | S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant Ascites | unknown | Phase 2 | 66 | China Medical University, ChinaOTHER | 1 | Jun 19, 2019 | clinicaltrials |
| NCT01047969 | Avoiding Surgery in Rectal Cancer After Pre-Operative Therapy | unknown | Phase 2 | 99 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jun 13, 2019 | clinicaltrials |
| NCT03981848 | Radiomics-based Non-invasive Classifier Research for HCC-related Liver Transplantation | unknown | — | 200 | Zhejiang UniversityOTHER | 0 | Jun 11, 2019 | clinicaltrials |
| NCT01372579 | Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients | unknown | Phase 2 | 30 | Northwestern UniversityOTHER | 1 | Jun 7, 2019 | clinicaltrials |
| NCT03966118 | Avelumab + Paclitaxel/ Ramucirumab (RAP) as Second Line Treatment in Gastro-esophageal Adenocarcinoma(AIO-STO-0218) | unknown | Phase 2 | 59 | P. C. Thuss-PatienceOTHER | 1 | Jun 3, 2019 | clinicaltrials |
| NCT03966209 | Safety and Efficacy of PD-1 Inhibitors in Patients With Liver Transplant | unknown | Phase 1 | 20 | Shanghai Zhongshan HospitalOTHER | 1 | May 31, 2019 | clinicaltrials |
| NCT03950102 | SBRT as Bridging Therapy for Hepatocellular Carcinoma Patients on Transplant Waitlist | unknown | N/A | 40 | The University of Hong KongOTHER | 1 | May 28, 2019 | clinicaltrials |
| NCT03880721 | By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation | unknown | — | 200 | Chinese PLA General HospitalOTHER | 1 | May 24, 2019 | clinicaltrials |
| NCT03947242 | Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Vinorelbine in Trastuzumab-refractory HER2-Positive Breast Cancer. | unknown | N/A | 48 | Henan Cancer HospitalOTHER_GOV | 0 | May 15, 2019 | clinicaltrials |
| NCT03138044 | Combined Ipsilateral Liver Lobe Devascularization and Alcohol Treatment of the Large Hepatocellular Carcinoma | unknown | N/A | 12 | The National Ribat UniversityOTHER | 1 | May 14, 2019 | clinicaltrials |
| NCT03634332 | Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC | unknown | Phase 2 | 35 | Pancreatic Cancer Research TeamOTHER | 1 | May 7, 2019 | clinicaltrials |
| NCT03939845 | A Prospective, Randomized, Multicenter Study of Comparison of TACE Combination With and Without EBRT for Hepatocellular Carcinoma With Portal Vein Tumor Thrombi | unknown | Phase 3 | 180 | Shanghai Zhongshan HospitalOTHER | 1 | May 7, 2019 | clinicaltrials |
| NCT03928964 | MEtatastic Renal Carcinoma LINes(MERLIN) | unknown | — | 440 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Apr 30, 2019 | clinicaltrials |
| NCT03932526 | Combined Use of Apatinib Mesylate and Vinorelbine Versus Single Use of Vinorelbine in Triple-negative Breast Cancer | unknown | Phase 2 | 184 | Liaoning Cancer Hospital & InstituteOTHER | 0 | Apr 30, 2019 | clinicaltrials |
| NCT03919253 | Pyrotinib in Combination With Nab-paclitaxel in Patients With HER2-positive Advanced Breast Cancer: an Exploratory Study | unknown | Phase 2 | 80 | Hebei Medical University Fourth HospitalOTHER | 0 | Apr 18, 2019 | clinicaltrials |
| NCT03812770 | Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC | unknown | Phase 2 | 150 | Sun Yat-sen UniversityOTHER | 1 | Apr 17, 2019 | clinicaltrials |
| NCT02781012 | Project Survival-Prospective Biomarker Discovery | unknown | — | 436 | Pancreatic Cancer Research TeamOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT03914352 | A Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic Resection | unknown | N/A | 40 | Cancer Hospital of Guangxi Medical UniversityOTHER | 1 | Apr 16, 2019 | clinicaltrials |
| NCT03899415 | TCR-Redirected T Cells Therapy in Patient With HBV Related HCC | unknown | Phase 1 | 10 | Beijing 302 HospitalOTHER | 1 | Apr 10, 2019 | clinicaltrials |
| NCT03910712 | Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBC(Pyrotinib) | unknown | Phase 2 | 250 | Peking Union Medical College HospitalOTHER | 0 | Apr 10, 2019 | clinicaltrials |
| NCT03908749 | A Real-world Clinical Study of Pyrotinib Maleate Tablets in the Treatment of Breast Cancer Patients With Positive Her-2 | unknown | — | 300 | Anhui Provincial HospitalOTHER_GOV | 0 | Apr 9, 2019 | clinicaltrials |
| NCT03908840 | Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular Carcinoma | unknown | Phase 1 | 12 | Evolve BiologicsINDUSTRY | 1 | Apr 9, 2019 | clinicaltrials |
| NCT03905317 | Bevacizumab and Radiotherapy for Oligometastasis of Lung Adenocarcinoma With Negative Driver Gene | unknown | Phase 2 | 66 | Sun Yat-sen UniversityOTHER | 1 | Apr 5, 2019 | clinicaltrials |
| NCT03869151 | Pretreatment Lymphocyte Monocyte Ratio on Outcome HCC Patients | unknown | — | 1 | Amany Aboalenen AminOTHER | 0 | Apr 2, 2019 | clinicaltrials |
| NCT03889769 | Evaluation of Accuracy of One-Step Nucleic Acid Amplification (OSNA) in Diagnosis of Lymph Node Metastases of Papillary Thyroid Carcinoma | unknown | — | 50 | University of CagliariOTHER | 1 | Mar 26, 2019 | clinicaltrials |
| NCT03876886 | The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency | unknown | Phase 3 | 200 | Chinese Academy of Medical SciencesOTHER | 1 | Mar 21, 2019 | clinicaltrials |
| NCT03881878 | TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After Surgery | unknown | Phase 1 / Phase 2 | 67 | Samsung Medical CenterOTHER | 1 | Mar 21, 2019 | clinicaltrials |
| NCT03884179 | Diagnosis of PCL With EUS-FNA and Cross-sectional Imaging - A Report of Accuracy | unknown | — | 58 | Sahlgrenska University HospitalOTHER | 0 | Mar 21, 2019 | clinicaltrials |
| NCT00807768 | Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer | unknown | Phase 3 | 601 | Gynecologic Oncology GroupNETWORK | 2 | Mar 20, 2019 | clinicaltrials |
| NCT03667885 | Non-Invasive Diagnostics of Small Renal Masses(NISar) | unknown | — | 160 | Odense University HospitalOTHER | 1 | Mar 19, 2019 | clinicaltrials |
| NCT03857815 | Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Patients With Hepatocellular Carcinoma | unknown | Phase 2 | 30 | Shanghai Zhongshan HospitalOTHER | 1 | Mar 19, 2019 | clinicaltrials |
| NCT03881501 | Evaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular Carcinoma | unknown | — | 2 | Huazhong University of Science and TechnologyOTHER | 1 | Mar 19, 2019 | clinicaltrials |
| NCT01295502 | Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Cancer | unknown | Phase 1 | 45 | Gynecologic Oncology GroupNETWORK | 1 | Mar 12, 2019 | clinicaltrials |
| NCT03847818 | Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Chemotherapy in Patients With HER2 Positive Breast Cancer | unknown | N/A | 268 | Shandong UniversityOTHER | 0 | Mar 1, 2019 | clinicaltrials |
| NCT01891539 | Observational Prospective Study on Chemoembolization With Doxorubicin for Unresectable Hepatocellular Carcinoma(DEBDOX) | unknown | — | 100 | International Group of Endovascular OncologyOTHER | 1 | Feb 27, 2019 | clinicaltrials |
| NCT02007148 | MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric Cancer(MICADO) | unknown | Phase 2 | 51 | International Group of Endovascular OncologyOTHER | 1 | Feb 27, 2019 | clinicaltrials |
| NCT03853928 | Probiotics in the Prevention of Hepatocellular Carcinoma in Cirrhosis | unknown | N/A | 280 | Austral University, ArgentinaOTHER | 0 | Feb 27, 2019 | clinicaltrials |
| NCT02232490 | Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L(Hepko-V5) | unknown | Phase 3 | 120 | Immunitor LLCINDUSTRY | 1 | Feb 26, 2019 | clinicaltrials |
| NCT03468244 | Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System Neoplasms | unknown | N/A | 24 | Changhai HospitalOTHER | 1 | Feb 26, 2019 | clinicaltrials |
| NCT03851887 | The Efficacy of Transarterial Chemoinfusion (TAI) Combine Stereotactic Body Radiation Therapy (SBRT) in Unresectable Hepatocellular Carcinoma (HCC) | unknown | Phase 2 | 33 | Sun Yat-sen UniversityOTHER | 1 | Feb 22, 2019 | clinicaltrials |
| NCT03851939 | The Efficacy of Transarterial Chemoinfusion (TAI) Combine Toripalimab in Advanced Hepatocellular Carcinoma (HCC) | unknown | Phase 2 | 65 | Sun Yat-sen UniversityOTHER | 1 | Feb 22, 2019 | clinicaltrials |
Data updated 24 days agoSource updated Jul 16, 2019source: clinicaltrials